Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 496 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

The Use of Magtrace®/Sentimag® in Sentinel Node Biopsy for Malignant Melanoma. The Magmen Study.

NCT03898687

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Completed

Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma

NCT02308553

Conditions: Cutaneous Malignant Melanoma, Melanoma, Melanoma, Cutaneous Malignant, +11 more
Locations: University Hospital Essen Essen, North Rhine-Westphalia, Germany

Elbeklinikum Buxtehude Buxtehude, Germany

SRH Wald-Klinikum Gera Gera, Germany

National Centre for Tumour Diseases (NCT) Heidelberg, Germany

View Trial Details

Completed

Uveal Melanoma and Brachytheraphy: Long-term Outcomes.

NCT04577742

Conditions: 106 Ruthenium Plaque Brachytherapy, Eye Diseases, Eye Neoplasms, +12 more
Locations: University of Naples "Federico II" Naples, Italy

View Trial Details

Completed

Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma

NCT02771340

Conditions: Choroid Diseases, Choroid Neoplasm, Choroid Neoplasms, +14 more
Locations: San Francisco, California, United States

Denver, Colorado, United States

Leawood, Kansas, United States

Boston, Massachusetts, United States

View Trial Details

Completed

Pheochromocytoma and Hemodynamic Instability

NCT04566406

Conditions: Cardiovascular Diseases, Hypertension, Neoplasms, +9 more
Locations: Not specified

View Trial Details

Completed

Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients

NCT00525031

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Melanoma Risk-Reduction Among Patients and Family Members

NCT00510302

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors

NCT02038218

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +29 more
Locations: Tulane University Medical Center New Orleans, Louisiana, United States

Detroit Clinical Research Centers Lansing, Michigan, United States

The University of Texas Health Science Center Houston, Texas, United States

View Trial Details

Completed

Long Term Quality of Life in Melanoma Patients in Netherlands

NCT03450876

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Amsterdam, Netherlands

View Trial Details

Completed

A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody (CheckMate 172)

NCT02156804

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Graz, Austria

Local Institution Innsbruck, Austria

Local Institution Salzburg, Austria

Local Institution Sankt Pölten, Austria

View all 170 locations

View Trial Details